Publications
Lichtenstein KA, Armon C, Moorman A, Buchacz K, Chmiel JS, Wood K, Brooks J, and the HOPS Investigators. Initiation of antiretroviral therapy at higher CD4+ T-cell counts reduces incidence of nucleoside analogue toxicities acutely and risk for later development with continued use of these agents in the HIV Outpatient (HOPS) cohort. In: Abstracts of the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention, Sidney, Australia, July 22-25, 2007.
Overton T, Mondy K, Bush T, Conley L, Kojic E, Henry K, Hammer J, Wood K, Lichtenstein K, Brooks J, and the SUN Study Investigators. Factors Associated with Low Bone Mineral Density in a Large Cohort of HIV-Infected US Adults: Baseline Results from the SUN Study. Poster 836. 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles. February 25-28, 2007.
Mondy K, Henry K, Overton T, Bush T, Conley L, Lichtenstein K, Kojic E, Mack W, Hodis H, Brooks J, and the SUN Study Investigators. Carotid Intima-media Thickness, Coronary Artery Calcium Scores, and Framingham Risk Scores among HIV-infected Patients in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy. Poster 810. 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles. February 25-28, 2007.
Lichtenstein KA, Armon C, Buchacz K, Moorman A, Wood K, Brooks JT. Early, uninterrupted Antiretroviral Therapy Is Associated with Improved Outcomes and Fewer Toxicities in the HIV Outpatient Study. Poster 769. 13th Conference on Retroviruses and Opportunistic Infections, Denver. February 5-9, 2006.
Lichtenstein KA, Armon C, Buchacz K, Moorman A, Wood K, Brooks JT. Analysis of Cardiovascular Risk Factors in the HIV Outpatient Study Group. Poster 735. 13th Conference on Retroviruses and Opportunistic Infections, Denver, Colorado, February 5-9, 2006.
More Publications by This Author
Link to Faculty Publications
Link to PubMed for more papers
